SCHEMBL6903858

SCHEMBL6903858

CCc1cc(Nc2nc(N)c3c(ncn3CCCCN3CCN(c4cc5[nH]c(C6CC6)c(C(=O)O)c(=O)c5cc4F)CC3)n2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6897934 0.90 — —
SCHEMBL6905532 0.84 — —
SCHEMBL6773431 0.83 KDM4E (0.52) —
SCHEMBL6905005 0.82 — —
SCHEMBL6905001 0.81 TLR9 (0.36) —
SCHEMBL6903649 0.81 ABL1 (0.35) —
SCHEMBL4743074 0.80 — —
Hydrochloric Acid SCHEMBL6902139 0.79 — —
SCHEMBL6899572 0.79 — —
SCHEMBL6904980 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401829-A4 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2004-10-27 — — EP disclosed
EP-1401829-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS Microbiotix, Inc. (US) 2004-03-31 — — EP disclosed
WO-2002102792-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX, INC. (US) 2002-12-27 — — WO disclosed
Send feedback